Tuberculosis treatment discontinuation and symptom persistence: an observational study of Bihar, India’s public care system covering >100,000,000 inhabitants-Reference-Cited by-同舟云学术

Tuberculosis treatment discontinuation and symptom persistence: an observational study of Bihar, India’s public care system covering >100,000,000 inhabitants

Published:2014-05-01 Issue:1 Volume:14 Page:
ISSN:1471-2458
Container-title:BMC Public Health
language:en
Short-container-title:BMC Public Health

Author:

Babiarz Kimberly S,Suen Sze-chuan,Goldhaber-Fiebert Jeremy D

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Link

http://link.springer.com/content/pdf/10.1186/1471-2458-14-418.pdf

Reference74 articles.

1. World Health Organization: Global Tuberculosis Control 2011. 2011, Geneva: World Health Organization

2. Government of India Ministry of Health and Family Welfare: Central TB Division: TB India 2011: Revised National TB Control Programme Annual Status Report. 2010, New Delhi, India: Government of India Ministry of Health and Family Welfare

3. Crofton J, Chaulet P, Maher D: Guidelines for The Management Of Drug-Resistant Tuberculosis. 1997, Geneva: World Health Organization

4. Heym B, Honore N, Truffot-Pernot C, Banerjee A, Schurra C, Jacobs WR, van Embden JD, Grosset JH, Cole ST: Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet. 1994, 344 (8918): 293-298. 10.1016/S0140-6736(94)91338-2.

5. Rowland K: Totally Drug-Resistant TB Emerges in India. Nature News. 2012, 2012

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barriers to engagement in the care cascade for tuberculosis disease in India: A systematic review of quantitative studies;PLOS Medicine;2024-05-28

2. Barriers to engagement by people with active tuberculosis in the care cascade in India: a systematic review of two decades of quantitative research;2023-05-15

3. Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase®);Antibiotics;2023-04-25

4. Molecular mechanism for the involvement of CYP2E1/NF-κB axis in bedaquiline-induced hepatotoxicity;Life Sciences;2023-02

5. Prevalence and predictive factors of tuberculosis treatment interruption in the Asia region: a systematic review and meta-analysis;BMJ Global Health;2023-01